Dietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-Ay mice

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Yang, Zhi Hong ^a   Miyahara, Hiroko ^a   Iwasaki, Yusuke ^a   Takeo, Jiro ^a   Katayama, Masashi ^a  

^a NIPPON SUISAN KAISHA LTD   (Japan)

Author keywords

Adipose mass; Long chain monounsaturated fatty acids; Pparg; Type 2 diabetes mellitus

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; CITRATE SYNTHASE; FATTY ACID; FATTY ACID TRANSPORTER; INSULIN; LEPTIN; LIPOPROTEIN LIPASE; LONG CHAIN MONOUNSATURATED FATTY ACID; MONOUNSATURATED FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SERUM AMYLOID A; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SIZE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; WHITE ADIPOSE TISSUE;

GLYCINE MAX; MUS;

EID: 84873045233     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-16     Document Type: Article

References (63)

1. Global and societal implications of the diabetes epidemic. Zimmet P, Alberti KG, Shaw J, Nature 2001 414 782 787 10.1038/414782a 11742409 (Pubitemid 34000780)
2. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. King H, Aubert RE, Herman WH, Diabetes Care 1998 21 1414 1431 10.2337/diacare.21.9.1414 9727886 (Pubitemid 28405191)
3. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, Thompson TJ, Diabetes Care 2001 24 1936 1940 10.2337/diacare.24.11.1936 11679460 (Pubitemid 33716504)
4. Prevalence, predisposition and prevention of type II diabetes. Cheng D, Nutr Metab 2005 2 29 10.1186/1743-7075-2-29 (Pubitemid 41765286)
5. Dietary fats and membrane function: implications for metabolism and disease. Hulbert AJ, Turner N, Storlien LH, Else PL, Biol Rev Camb Philos Soc 2005 80 155 169 10.1017/S1464793104006578 15727042 (Pubitemid 40204269)
6. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Abete I, Goyenechea E, Zulet MA, Martínez JA, Nutr Metab Cardiovasc 2011 Suppl 2 1 B15
7. Metabolic fate of saturated and monounsaturated dietary fats: the Mediterranean diet revisited from epidemiological evidence to cellular mechanisms. Bergouignan A, Momken I, Schoeller DA, Simon C, Blanc S, Prog Lipid Res 2009 48 128 147 10.1016/j.plipres.2009.02.004 19275915
8. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Gillingham LG, Harris-Janz S, Jones PJ, Lipids 2011 46 209 228 10.1007/s11745-010-3524-y 21308420
9. Dietary interventions for metabolic syndrome: role of modifying dietary fats. Kien CL, Curr Diab Rep 2009 9 43 50 10.1007/s11892-009-0009-6 19192424
10. Effects of dietary palmitoleic acid on plasma lipoprotein profile and aortic cholesterol accumulation are similar to those of other unsaturated fatty acids in the F1B golden Syrian hamster. Matthan NR, Dillard A, Lecker JL, Ip B, Lichtenstein AH, J Nutr 2009 139 215 221 19106316
11. The composition of the Eskimo food in north western Greenland. Bang HO, Dyerberg J, Sinclair HM, Am J Clin Nutr 1980 33 2657 2661 7435433 (Pubitemid 11172006)
12. Fatty acid composition of the plasma lipids in Greenland Eskimos. Dyerberg J, Bang HO, Hjorne N, Am J Clin Nutr 1975 28 958 966 1163480
13. Changes in lipids of young and adult saury cololabis saira (Pisces). Ota T, Takagi T, Kosaka S, Mar Ecol Prog Ser 1980 3 11 17
14. Long-chain monoethylenic alcohol and acid isomers in lipids of copepods and capelin. Pascal JC, Ackman RG, Chem Phys Lipids 1976 16 219 223 10.1016/0009-3084(76)90029-3
15. Seasonal variation in some of the lipid components of sprats (Sprattus sprattus). Hardy R, Mackie P, J Sci Food Agric 1969 20 193 198 10.1002/jsfa.2740200401 5782392
16. Fatty alcohols in capelin, herring and mackerel oils and muscle lipids: I fatty alcohol details linking dietary copepod fat with certain fish depot fats. Ratnayake WN, Ackman RG, Lipids 1979 14 795 803 10.1007/BF02533518 491864
17. Species-specific differences in intact wax esters of Calanus hyperboreus and C. finmarchicus from Fram Strait-Greenland Sea. Graeve M, Kattner G, Mar Chem 1992 39 269 281 10.1016/0304-4203(92)90013-Z
18. Lipid composition of zooplankton in relation to the sub-arctic food web. Falk-Petersen S, Sargent JR, Tande KS, Polar Biol 1987 8 115 120 10.1007/BF00297065
19. Dietary saury oil reduces hyperglycemia and hyperlipidemia in diabetic KKAy mice and in diet-induced obese C57BL/6 J mice by altering gene expression. Yang ZH, Miyahara H, Takemura S, Hatanaka A, Lipids 2011 46 425 434 10.1007/s11745-011-3553-1 21465306
20. Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet. Yang ZH, Miyahara H, Takeo J, Hatanaka A, Katayama M, Lipids Health Dis 2011 10 189 10.1186/1476-511X-10-189 22027268
21. Beneficial effects of dietary fish-oil-derived monounsaturated fatty acids on metabolic syndrome risk factors and insulin resistance in mice. Yang ZH, Miyahara H, Mori T, Doisaki N, Hatanaka A, J Agric Food Chem 2011 59 7482 7489 10.1021/jf201496h 21627145
22. General survey of diabetic features of yellow KK mice. Iwatsuka H, Shino A, Suzuoki Z, Endocrinol Jpn 1970 17 23 35 10.1507/endocrj1954.17.23 5468422
23. Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone. Castle CK, Colca JR, Melchior GW, Arterioscler Thromb 1993 13 302 309 10.1161/01.ATV.13.2.302 8427865 (Pubitemid 23056804)
24. A simple method for the isolation and purification of total lipids from animal tissues. Folch J, Lees M, Stanley GHS, J Biol Chem 1956 226 497 509
25. Direct transesterification of all classes of lipids in a one-step reaction. Lepage G, Roy CC, J Lipid Res 1986 27 114 120 3958609 (Pubitemid 16045295)
26. Nat Dyslipidemia in type 2 diabetes mellitus. Mooradian AD, Clin Pract Endocrinol Metab 2009 5 150 159 10.1038/ncpendmet1066
27. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Rader DJ, Am J Med 2007 120 12 S18 17826041
28. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Choi K, Kim YB, Korean J Intern Med 2010 25 119 129 10.3904/kjim.2010.25.2.119 20526383
29. Slow glucose removal and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR, Ann Intern Med 1990 113 909 915 2240915
30. Decreased insulin activation of glycogen synthesis in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with NIDDM. Vaag A, Henrikssen JE, Beck-Nielsen H, J Clin Invest 1992 89 782 788 10.1172/JCI115656 1541672
31. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity. Heptulla RA, Tamborlane WV, Cavaghan M, Bronson M, Limb C, Ma YZ, Sherwin RS, Caprio S, Pediatr Res 2000 47 628 633 10.1203/00006450-200005000-00012 10813588 (Pubitemid 30249851)
32. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J, Diabetes Care Suppl 2008 2 262 S268
33. Mechanism of free fatty acid-induced insulin resistance in humans. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI, J Clin Invest 1996 97 2859 2865 10.1172/JCI118742 8675698 (Pubitemid 26197099)
34. Free fatty acids and insulin resistance. Delarue J, Magnan C, Curr Opin Clin Nutr Metab Care 2007 10 142 148 10.1097/MCO.0b013e328042ba90 17285001 (Pubitemid 46220305)
35. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JP, Pinkney JH, Postgrad Med J 2006 82 280 284 10.1136/pmj.2005.039032 16597817
36. Weight loss in obese diabetic and non-diabetic individuals and long-term diabetes outcomes-a systematic review. Aucott L, Poobalan A, Smith WC, Avenell A, Jung R, Broom J, Grant AM, Diabetes Obes Metab 2004 6 85 94 10.1111/j.1462-8902.2004.00315.x 14746573 (Pubitemid 38220100)
37. Insulin sensitivity: modulation by nutrients and inflammation. Schenk S, Saberi M, Olefsky JM, J Clin Invest 2008 118 2992 3002 10.1172/JCI34260 18769626
38. Inflammation and metabolic disorders. Hotamisligil GS, Nature 2006 444 860 867 10.1038/nature05485 17167474 (Pubitemid 46024993)
39. Diet-induced adipocyte number increase in adult rats: a new model of obesity. Faust IM, Johnson PR, Stern JS, Hirsh J, Am J Physiol 1978 235 279 286
40. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Rizzo WB, Leshner RT, Odone A, Dammann AL, Craft DA, Jensen ME, Jennings SS, Davis S, Jaitly R, Sgro JA, Neurology 1989 39 1415 1422 10.1212/WNL.39.11.1415 2682348 (Pubitemid 19285993)
41. Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy. Asano J, Suzuki Y, Yajima S, Inoue K, Shimozawa N, Kondo N, Murase M, Orii T, Brain Dev 1994 16 454 458 10.1016/0387-7604(94)90007-8 7694994
42. Physiopathological effects of rapeseed oil: a review. Borg K, Acta Med Scand Suppl 1975 585 5 13 766575
43. Unsaturated fatty acids as cytoprotective agents in the pancreatic beta-cell. Morgan NG, Dhayal S, Prostaglandins Leukot Essent Fatty Acids 2010 82 231 236 10.1016/j.plefa.2010.02.018 20206490
44. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS, Cell 2008 134 933 944 10.1016/j.cell.2008.07.048 18805087
45. Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women. Lindgärde F, Vessby B, Ahrén B, Am J Clin Nutr 2006 84 1009 1013 17093151 (Pubitemid 44730369)
46. Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Paillard F, Catheline D, Duff FL, Bouriel M, Deugnier Y, Pouchard M, Daubert JC, Legrand P, Nutr Metab Cardiovasc Dis 2008 18 436 440 10.1016/j.numecd.2007.02.017 18068341
47. The mechanisms of action of PPARs. Berger J, Moller DE, Annu Rev Med 2002 53 409 435 10.1146/annurev.med.53.082901.104018 11818483 (Pubitemid 34177889)
48. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Lemberger T, Desvergne B, Wahli W, Annu Rev Cell Dev Biol 1996 12 335 363 10.1146/annurev.cellbio.12.1.335 8970730 (Pubitemid 26422717)
49. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Tamori Y, Masugi J, Nishino N, Kasuga M, Diabetes 2002 51 2045 2055 10.2337/diabetes.51.7.2045 12086932 (Pubitemid 34729007)
50. PPAR gamma and the treatment of insulin resistance. Olefsky JM, Saltiel AR, Trends Endocrinol Metab 2000 11 362 368 10.1016/S1043-2760(00)00306-4 11042466
51. Thiazolidinediones in the treatment of insulin resistance and type 2 diabetes. Saltiel AR, Olefsky JM, Diabetes 1996 45 1661 1669 10.2337/diabetes.45.12.1661 8922349 (Pubitemid 26398943)
52. Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. Goldberg IJ, Eckel RH, Abumrad NA, J Lipid Res 2009 50 86 S90 19033209
53. Expression cloning and characterization of a novel long chain faty acid transport protein. Schaffer JE, Lodish HF, Cell 1994 79 427 436 10.1016/0092-8674(94)90252-6 7954810 (Pubitemid 24346058)
54. Leptin in relation to the lipodystrophy-associated metabolic syndrome. Mantzoros CS, Diabetes Metab J 2012 36 181 189 10.4093/dmj.2012.36.3.181 22737657
55. Acute and chronic regulation of leptin synthesis, storage, and secretion by insulin and dexamethasone in human adipose tissue. Lee MJ, Wang Y, Ricci MR, Sullivan S, Russell CD, Fried SK, Am J Physiol Endocrinol Metab 2007 292 858 E864 17122089
56. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Kallen CB, Lazar MA, Proc Natl Acad Sci U S A 1996 93 5793 5796 10.1073/pnas.93.12.5793 8650171 (Pubitemid 26191315)
57. Adipose tissue, inflammation, and cardiovascular disease. Berg AH, Scherer PE, Circ Res 2005 96 939 949 10.1161/01.RES.0000163635.62927.34 15890981 (Pubitemid 40712793)
58. Lipid oxidation is reduced in obese human skeletal muscle. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA, Am J Physiol Endocrinol Metab 2000 279 1039 E1044 11052958
59. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. Stephens FB, Constantin-Teodosiu D, Greenhaff PL, J Physiol 2007 581 431 444 10.1113/jphysiol.2006.125799 17331998 (Pubitemid 46831747)
60. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Ortenblad N, Mogensen M, Petersen I, Højlund K, Levin K, Sahlin K, Beck-Nielsen H, Gaster M, Biochim Biophys Acta 2005 1741 206 214 10.1016/j.bbadis.2005.04.001 15894466 (Pubitemid 40825006)
61. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry JD, Diabetes 2001 50 123 130 10.2337/diabetes.50.1.123 11147777 (Pubitemid 32047990)
62. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance. Sebastián D, Herrero L, Serra D, Asins G, Hegardt FG, Am J Physiol Endocrinol Metab 2007 292 677 E686 17062841
63. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. Perdomo G, Commerford SR, Richard AM, Adams SH, Corkey BE, O'Doherty RM, Brown NF, J Biol Chem 2004 279 27177 27186 10.1074/jbc.M403566200 15105415 (Pubitemid 38812554)